Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways
Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways have?
Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways has 126 citations in the OpenAlex counts ScholarIQ stores.
When was Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways published?
Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways has 2014 year in the ScholarIQ index.
What is the open-access status of Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways?
Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways has closed oa status in the ScholarIQ index.
What is the DOI of Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways?
The DOI for Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways is on the source record.
What is the PMID of Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways?
The PMID for Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways is on the source record.
What is the OpenAlex record for Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways?
The OpenAlex for Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways is on the source record.